Sanofi (SNY) Shares Sold by Courier Capital LLC
Courier Capital LLC reduced its stake in shares of Sanofi (NYSE:SNY) by 3.4% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 31,259 shares of the company’s stock after selling 1,089 shares during the period. Courier Capital LLC’s holdings in Sanofi were worth $1,498,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently modified their holdings of SNY. Bank of New York Mellon Corp boosted its position in shares of Sanofi by 1.0% during the 1st quarter. Bank of New York Mellon Corp now owns 305,326 shares of the company’s stock worth $13,816,000 after purchasing an additional 3,013 shares in the last quarter. BNP Paribas Arbitrage SA boosted its position in shares of Sanofi by 69.8% during the 1st quarter. BNP Paribas Arbitrage SA now owns 17,692 shares of the company’s stock worth $801,000 after purchasing an additional 7,275 shares in the last quarter. TD Asset Management Inc. boosted its position in shares of Sanofi by 7.9% during the 1st quarter. TD Asset Management Inc. now owns 188,689 shares of the company’s stock worth $8,538,000 after purchasing an additional 13,797 shares in the last quarter. Ameriprise Financial Inc. boosted its position in shares of Sanofi by 8.0% during the 1st quarter. Ameriprise Financial Inc. now owns 495,865 shares of the company’s stock worth $22,421,000 after purchasing an additional 36,873 shares in the last quarter. Finally, Eagle Asset Management Inc. purchased a new stake in shares of Sanofi during the 1st quarter worth $260,000. Institutional investors own 9.33% of the company’s stock.
Several equities research analysts recently commented on SNY shares. BidaskClub upgraded shares of Sanofi from a “hold” rating to a “buy” rating in a research report on Friday, June 23rd. Zacks Investment Research upgraded shares of Sanofi from a “hold” rating to a “buy” rating and set a $55.00 price objective on the stock in a research report on Friday, June 2nd. HSBC Holdings plc upgraded shares of Sanofi from a “reduce” rating to a “hold” rating in a research report on Wednesday, August 30th. Argus reiterated a “buy” rating and issued a $55.00 price objective on shares of Sanofi in a research report on Friday, September 1st. Finally, Cowen and Company reiterated a “market perform” rating and issued a $52.00 price objective (up from $46.00) on shares of Sanofi in a research report on Tuesday, August 1st. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and five have issued a buy rating to the stock. Sanofi has an average rating of “Hold” and an average price target of $54.00.
Sanofi (NYSE:SNY) traded up 0.56% on Thursday, hitting $48.78. 222,728 shares of the stock were exchanged. The company has a market cap of $122.51 billion, a PE ratio of 11.62 and a beta of 0.88. Sanofi has a 52 week low of $36.81 and a 52 week high of $50.24. The company’s 50-day moving average is $48.26 and its 200-day moving average is $47.26.
Sanofi (NYSE:SNY) last released its quarterly earnings results on Monday, July 31st. The company reported $0.74 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.74. The business had revenue of $8.66 billion during the quarter, compared to analyst estimates of $8.71 billion. Sanofi had a return on equity of 25.34% and a net margin of 25.89%. The company’s revenue for the quarter was down 2.3% compared to the same quarter last year. On average, analysts predict that Sanofi will post $3.34 earnings per share for the current year.
In other Sanofi news, major shareholder Sanofi acquired 60,595 shares of Sanofi stock in a transaction that occurred on Wednesday, August 23rd. The stock was purchased at an average cost of $478.98 per share, with a total value of $29,023,793.10. The transaction was disclosed in a filing with the SEC, which is available at this link. 1.00% of the stock is currently owned by corporate insiders.
WARNING: “Sanofi (SNY) Shares Sold by Courier Capital LLC” was originally posted by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The original version of this news story can be accessed at https://www.dailypolitical.com/2017/09/14/sanofi-sny-shares-sold-by-courier-capital-llc.html.
Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company’s segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company’s pharmaceuticals operations.
Want to see what other hedge funds are holding SNY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sanofi (NYSE:SNY).
Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.